Biomedical Research Centre, Oxford University, New York, USA
Opinion
Dopaminergic Medications for Parkinson's Disease
Author(s): Javier Carlos*
DOI:
10.37421/2795-6172.2022.6.159
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 